215 related articles for article (PubMed ID: 29955824)
1. Evaluation of Linguistic Markers of Word-Finding Difficulty and Cognition in Parkinson's Disease.
Smith KM; Ash S; Xie SX; Grossman M
J Speech Lang Hear Res; 2018 Jul; 61(7):1691-1699. PubMed ID: 29955824
[TBL] [Abstract][Full Text] [Related]
2. Pausing before verb production is associated with mild cognitive impairment in Parkinson's disease.
Andrade EIN; Manxhari C; Smith KM
Front Hum Neurosci; 2023; 17():1102024. PubMed ID: 37113321
[TBL] [Abstract][Full Text] [Related]
3. Communication impairment in Parkinson's disease: Impact of motor and cognitive symptoms on speech and language.
Smith KM; Caplan DN
Brain Lang; 2018 Oct; 185():38-46. PubMed ID: 30092448
[TBL] [Abstract][Full Text] [Related]
4. Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease.
Holtgraves T; McNamara P; Cappaert K; Durso R
Brain Cogn; 2010 Mar; 72(2):189-96. PubMed ID: 19751960
[TBL] [Abstract][Full Text] [Related]
5. Effect of Parkinson's disease on the production of structured and unstructured speaking tasks: respiratory physiologic and linguistic considerations.
Huber JE; Darling M
J Speech Lang Hear Res; 2011 Feb; 54(1):33-46. PubMed ID: 20844256
[TBL] [Abstract][Full Text] [Related]
6. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
Ozdilek B; Kenangil G
Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlates of repetitive speech disorders in Parkinson's disease.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Sato M; Hattori M; Kawabata K; Hara K; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
J Neurol Sci; 2019 Jun; 401():67-71. PubMed ID: 31029883
[TBL] [Abstract][Full Text] [Related]
9. Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.
Becker S; Bäumer A; Maetzler W; Nussbaum S; Tkaczynska Z; Sulzer P; Timmers M; Van Nueten L; Salvadore G; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
Neuropsychology; 2020 May; 34(4):447-455. PubMed ID: 32191056
[TBL] [Abstract][Full Text] [Related]
10. Reading fluency in Spanish patients with Parkinson's disease: A reading prosody examination.
Pérez-Sánchez MDC; González-Nosti M; Cuetos F; Álvarez-Cañizo M
Int J Lang Commun Disord; 2023 Mar; 58(2):357-375. PubMed ID: 36269041
[TBL] [Abstract][Full Text] [Related]
11. Impairments of speech fluency in Lewy body spectrum disorder.
Ash S; McMillan C; Gross RG; Cook P; Gunawardena D; Morgan B; Boller A; Siderowf A; Grossman M
Brain Lang; 2012 Mar; 120(3):290-302. PubMed ID: 22099969
[TBL] [Abstract][Full Text] [Related]
12. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
[TBL] [Abstract][Full Text] [Related]
13. Speech and communication in Parkinson's disease: a cross-sectional exploratory study in the UK.
Barnish MS; Horton SMC; Butterfint ZR; Clark AB; Atkinson RA; Deane KHO
BMJ Open; 2017 May; 7(5):e014642. PubMed ID: 28554918
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Parkinson's Disease on Breath Pauses and Their Relationship to Speech Impairment: A Longitudinal Study.
Darling-White M; Huber JE
Am J Speech Lang Pathol; 2020 Nov; 29(4):1910-1922. PubMed ID: 32693630
[TBL] [Abstract][Full Text] [Related]
16. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
[TBL] [Abstract][Full Text] [Related]
17. Language planning and pauses in story retell: Evidence from aging and Parkinson's disease.
Lee J; Huber J; Jenkins J; Fredrick J
J Commun Disord; 2019; 79():1-10. PubMed ID: 30844602
[TBL] [Abstract][Full Text] [Related]
18. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
[TBL] [Abstract][Full Text] [Related]
19. Linguistic features of dysfluencies in Parkinson Disease.
Reif AE; Goberman AM
J Fluency Disord; 2021 Dec; 70():105845. PubMed ID: 33780692
[TBL] [Abstract][Full Text] [Related]
20. Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.
Mao CJ; Wang F; Chen JP; Yang YP; Chen J; Huang JY; Liu CF
Clin Interv Aging; 2017; 12():1637-1644. PubMed ID: 29070942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
